HOME >> MEDICINE >> NEWS
Alefacept effective in treating patients with psoriasis

CHICAGO Patients with psoriasis treated with the drug alefacept experienced a reduction in severity of their skin disease, according to an article in the December issue of The Archives of Dermatology, one of the JAMA/Archives journals.

Psoriasis is a chronic, inflammatory skin disorder. According to the article, scientific and clinical evidence suggests that T cells, specialized cells involved in the immune response, are involved in psoriasis. Skin severely affected by psoriasis has been observed to have high levels of CD4+ and CD8+ memory T cells (two types of T cells). Previous experimental studies have shown that elimination of T cells reduced the severity of psoriasis.

Kenneth B. Gordon, M.D., of Loyola University Medical Center, Maywood, Ill., and colleagues examined the effects of intravenous alefacept on the severity of psoriasis and T cell levels.

The researchers conducted a phase 3 clinical trial involving 553 patients with chronic psoriasis. The patients were randomized into one of three groups. Each group participated in a 12 week course of treatment (or placebo), followed by a twelve week period of observation without any drugs. Then, for eligible patients, there was a second 12 week course of treatment (or placebo) and another 12 weeks of observation.

  • group 1 7.5 milligrams of intravenous alefacept each week for both courses
  • group 2 7.5 milligrams intravenous alefacept each week in the first course, and 7.5 milligrams intravenous placebo each week for the second course
  • group 3 7.5 milligrams intravenous placebo each week in the first course, and 7.5 milligrams intravenous alefacept each week in the second course

    The researchers found that one or two courses of alefacept reduced CD4+ and CD8+ memory T cell counts. Patients who received alefacept in course 1 with the largest decrease in T cell counts experienced the greatest reduction in disease severity. The benefits
    '"/>



  • Contact: Joanne Swanson
    708-216-2445
    JAMA and Archives Journals
    15-Dec-2003


    Page: 1 2

    Related medicine news :

    1. Strategy effective against drug resistant tuberculosis
    2. Study shows patch therapy may be as effective as oral medications
    3. Chronic pain treatments more effective when taken together, new study shows
    4. Geodon effective in psychiatric emergencies; Sharply reduces time in restraints
    5. Costs of antidepressants could have funded effective alternatives
    6. New ways to design safer & more effective topical (transdermal) drug delivery announced in the PNAS
    7. Government wasting your taxpayer money on ineffective drug cure
    8. Neurobehavioral function during coma, stroke rehabilitation effective for elderly
    9. European folic acid policies are not effective enough
    10. How effective are herbal supplements in reducing illnesses in children?
    11. Cognitive behavioral therapy and medication is effective in the treatment of panic disorder

    Post Your Comments:
    *Name:
    *Comment:
    *Email:


    (Date:12/5/2018)... (PRWEB) , ... December 05, 2018 , ... ... be one of the first plastic surgery practices in Houston to offer the ... to bringing his patients an innovative range of surgical and noninvasive techniques to ...
    (Date:12/5/2018)... ... December 05, 2018 , ... ... Resourcing, and Consulting services, announced its new office location in Paris, France during ... growth of clinical trial operations in Europe and additional in-country personnel. , “The ...
    (Date:12/5/2018)... ... , ... Domenic Palmieri has been named chief operating officer ... for the executive oversight of operations for three core divisions within HM, including ... position,” Tom Doran, president, HM Insurance Group, said. “And while we had significant ...
    (Date:11/29/2018)... NEW YORK (PRWEB) , ... November 29, 2018 ... ... a bold mission to alleviate and treat chronic pain without opiates. This new ... tailored treatments to reduce or eliminate chronic pain for both children and adults. ...
    (Date:11/28/2018)... ... ... Shareholders Lori G. Cohen and Sara K. Thompson of the ... Annual American Conference Institute (ACI) Conference on Drug & Medical Device Litigation. The three-day ... at the New York Marriott Marquis. The firm is sponsoring the conference, hosting a ...
    Breaking Medicine News(10 mins):
    (Date:12/5/2018)... S.D. (PRWEB) , ... December 05, 2018 , ... Two ... inaugural $1 million Sanford Lorraine Cross Award. , Jean Bennett, M.D., Ph.D., and ... form of blindness, accepted the award on Dec. 4 at Sanford Health, headquartered in ...
    (Date:11/29/2018)... ... 2018 , ... Windsor Gardens Healthcare Center of the Valley (“Windsor Gardens”), a ... they were selected by the California Association of Health Facilities (CAHF) as only one ... , The California Department of Public Health awarded a grant of $700,000 to CAHF ...
    (Date:11/28/2018)... THE WOODLANDS, Texas (PRWEB) , ... November 28, ... ... from Rigaku Corporation has been published and is available to ... newsletter concentrating on single crystal X-ray diffraction, published by Rigaku Oxford Diffraction ...
    Breaking Medicine Technology:
    Cached News: